Press release
$789.7 billion Injectable Drug Delivery Market 2018: Global Growth Factors, Applications, Regional Analysis, Key Players And Forecasts to 2024
Global Injectable Drug Delivery Market 2018-2024
Global Injectable Drug Delivery Market is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Injectable drug delivery market has the largest market segment in Drug delivery market.
North America Injectable Drug Delivery Market is expected to reach USD 354.53billion by 2024 from USD 154.05 billion in 2016, at a CAGR of 5.4% in the forecast period 2017 to 2024.
Europe Injectable Drug Delivery Market is expected to reach USD 265.0 billion by 2024 from USD 107.4 billion in 2016, at a CAGR of 11.9 % in the forecast period 2017 to 2024.
Click Here For Free Sample Report @: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-injectable-drug-delivery-market
Some of the Top Key Players:
Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, and Teva Pharmaceuticals Industries Ltd.
Pfizer:
Incorporated in June 1942 and headquartered in New York, U.S. Pfizer Inc., is engaged in discovering, developing and, manufacturing of healthcare products. Pfizer Inc., operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The Company’s IH segment concentrates on creating and commercializing immunizations and prescriptions that enhance patients’ lives, and in addition products for the end user health care.
To Know More About in short click here: https://youtu.be/eSCDbJ9zmsU
Becton, Dickinson and Company:
Founded in 1897 as Becton, Dickinson and Company and head quartered in New Jersey, U.S. is focused on developing, manufacturing and sales of medical supplies, devices, laboratory equipment and diagnostic products. The company operates through two business segments: BD Medical and BD Life Sciences.
Request for Detail TOC@ http://databridgemarketresearch.com/toc/?dbmr=global-injectable-drug-delivery-market
Company Share Study:
The report also includes company’s share analysis for the major companies operating in this market by major regions as North America, Europe and Asia Pacific. The details of mergers and acquisitions, product launches, expansions, and product life cycle matrix are also a part of this report.
The Injectable drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
Recent Growths:
The major factors driving the growth of this market are the increasing use of biologics, rising prevalence of chronic diseases, increasing occurrence of needle stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors increase the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes. On the other hand, safety concerns regarding the use of injectable, increased risk of blood-borne infections due to injectable and presence of other drug delivery methods (such as oral and transdermal) may hinder the growth of the market.
Have Any Query? Ask Our Expert: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-injectable-drug-delivery-market
Other Market Insights:
North America injectable drug delivery market is expected to reach USD 354.5 billion by 2024 from USD 154.0 billion in 2016, at a CAGR of 11.0% in the forecast period 2017 to 2024.
Read More: http://databridgemarketresearch.com/reports/north-america-injectable-drug-delivery-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release $789.7 billion Injectable Drug Delivery Market 2018: Global Growth Factors, Applications, Regional Analysis, Key Players And Forecasts to 2024 here
News-ID: 975269 • Views: …
More Releases from Data Bridge Market Research
Piriformis Syndrome Treatment Market Size to Reach USD 418.25 million by 2033, G …
As per Data Bridge Market Research analysis, the Piriformis Syndrome Treatment Market was estimated at USD 0.26 billion in 2025. The market is expected to grow from USD 262.42 million in 2025 to USD 418.25 million by 2033, at a CAGR of 6.00% during the forecast period with driven by the rising demand for minimally invasive pain management therapies, increasing prevalence of musculoskeletal disorders, advancements in diagnostic imaging, and growing…
Neurological Disorder Drugs Market Outlook (2026-2032): 5.9% CAGR Driving Growth …
"As per Data Bridge Market Research analysis, the Neurological Disorder Drugs Market was estimated at USD 99.86 billion in 2025. The market is expected to grow from USD 105.76 billion in 2026 to USD 149.17 billion in 2032, at a CAGR of 5.9% during the forecast period with driven by the rising demand for advanced neurotherapeutics, increasing prevalence of neurological diseases, and expanding adoption of targeted biologics and precision medicine…
Etanercept Market Size, Share & Industry Trends Analysis Report, 2026-2033: Mark …
As per Data Bridge Market Research analysis, the Etanercept Market was estimated at USD 20.05 billion in 2025. The market is expected to grow from USD 20.79 billion in 2026 to USD 26.81 billion in 2033, at a CAGR of 3.7% during the forecast period with driven by the rising demand for biologic therapies for autoimmune disorders, expanding biosimilar adoption, increasing prevalence of rheumatoid arthritis and psoriasis, and continuous advancements…
E-Clinical Solutions Market Size, Share & Industry Analysis, By Product, Deploym …
As per Data Bridge Market Research analysis, the E-Clinical Solutions Market was estimated at USD 10.62 billion in 2025. The market is expected to grow from USD 12.06 billion in 2026 to USD 25.79 billion in 2032, at a CAGR of 13.50% during the forecast period, driven by the rising demand for decentralized clinical trials, increasing adoption of cloud-based clinical data management platforms, growing pharmaceutical R&D investments, and expanding integration…
More Releases for Injectable
Key Small Molecule Injectable Drugs Market Trend for 2025-2034: Small Molecule I …
What Is the Future Outlook for the Small Molecule Injectable Drugs Market's Size and Growth Rate?
The small molecule injectable drugs market has grown rapidly in recent years. It will rise from $219.57 billion in 2024 to $248.2 billion in 2025, at a CAGR of 13.0%. The growth is attributed to the rising prevalence of chronic diseases, an aging population, government initiatives, increased healthcare spending, and improvements in manufacturing processes.
The small…
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Facial Injectable Market Size to Hit $7.5 Billion by 2028 | Facial Injectable In …
According to our experience research team, Facial Injectable Market was valued at USD 4.4 Billion in 2021, and the global Facial Injectable industry is projected to reach a value of USD 7.5 Billion by 2028, at a CAGR of 9.4% during the forecast period 2022-2028
The report is focused on gaining various Facial Injectable market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the global…
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis.
The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that…
Global Injectable Drug Delivery Devices Market | Global Injectable Drug Delivery …
The injectable drug delivery devices market involves of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors. The market contains the sales of the Injectable devices that have been comprehensively utilized for several routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and several others to cure the medical conditions vacillating from cancer to autoimmune disorders. The injectable drug delivery devices utilized in hospitals, clinics…
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of…
